Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The Veteran's severe actinic damage with a history of multiple non-melanomatous skin cancers has been granted a 30 percent evaluation, effective November 17, 2005.

The deciding factor: The evidence showed numerous sites of skin cancer and actinic keratoses on various parts of the body, including the face and ears, with visible or palpable tissue loss and gross distortion of the right ear. This met the criteria for a 30 percent evaluation under Diagnostic Code 7818.

Claimed conditions
lung disability, asbestosis, chronic obstructive pulmonary disease (COPD), multiple non-melanomatous skin cancers
How they argued it
Not specified
Exposure basis
None
Rating assigned
30%
Decision date
June 10, 2011
Citation
1122560

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1122560.

What this means for you

A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.